Sign in

CIK 0001601485

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

Elicio Therapeutics, Inc.

Sign in to watch
Ticker
ELTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
113430072
Phone
+1 857-209-0050
Business address
451 D STREET, 5TH FLOOR, BOSTON, MA, 02210
Former names
Angion Biomedica Corp.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-07-16 DeMuth Peter Chief Scientific Officer Grant or award · Stock Option (Right to Buy) +52,832 52,832
2026-02-02 DeMuth Peter Chief Scientific Officer Grant or award +20,800 21,543
2026-02-02 DeMuth Peter Chief Scientific Officer Grant or award · Stock Option (Right to Buy) +41,600 41,600
2025-12-09 DeMuth Peter Chief Scientific Officer Exercise or conversion +362 $4.41 $2K 743
2025-12-09 DeMuth Peter Chief Scientific Officer Exercise or conversion · Stock Option (Right to Buy) −362 0
2025-02-03 DeMuth Peter Chief Scientific Officer Grant or award · Stock Option (Right to Buy) +44,400 44,400
2024-12-16 DeMuth Peter Chief Scientific Officer Exercise or conversion +381 $4.41 $2K 381
2024-12-16 DeMuth Peter Chief Scientific Officer Exercise or conversion · Stock Option (Right to Buy) −381 0
2024-09-30 DeMuth Peter Chief Scientific Officer Grant or award · Stock Option (Right to Buy) +29,800 29,800
2024-02-01 DeMuth Peter Chief Scientific Officer Grant or award · Stock Option (right to buy) +29,800 29,800
2024-02-01 DeMuth Peter Chief Scientific Officer Grant or award · Stock Option (right to buy) +342 342

Page 1 of 1 · 11 trades